BMI and pneumonia outcomes in critically ill covid-19 patients: An international multicenter study.


Journal

Obesity (Silver Spring, Md.)
ISSN: 1930-739X
Titre abrégé: Obesity (Silver Spring)
Pays: United States
ID NLM: 101264860

Informations de publication

Date de publication:
09 2021
Historique:
received: 03 05 2021
accepted: 05 05 2021
pubmed: 10 5 2021
medline: 21 10 2021
entrez: 9 5 2021
Statut: ppublish

Résumé

Previous studies have unveiled a relationship between the severity of coronavirus disease 2019 (COVID-19) pneumonia and obesity. The aims of this multicenter retrospective cohort study were to disentangle the association of BMI and associated metabolic risk factors (diabetes, hypertension, hyperlipidemia, and current smoking status) in critically ill patients with COVID-19. Patients admitted to intensive care units for COVID-19 in 21 centers (in Europe, Israel, and the United States) were enrolled in this study between February 19, 2020, and May 19, 2020. Primary and secondary outcomes were the need for invasive mechanical ventilation (IMV) and 28-day mortality, respectively. A total of 1,461 patients were enrolled; the median (interquartile range) age was 64 years (40.9-72.0); 73.2% of patients were male; the median BMI was 28.1 kg/m In critically ill COVID-19 patients, a linear association between BMI and the need for IMV, independent of other metabolic risk factors, and a nonlinear association between BMI and mortality risk were observed.

Identifiants

pubmed: 33966355
doi: 10.1002/oby.23223
pmc: PMC8242742
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1477-1486

Informations de copyright

© 2021 The Obesity Society.

Références

Clin Infect Dis. 2020 Jul 28;71(15):896-897
pubmed: 32271368
J Gynecol Obstet Hum Reprod. 2020 Sep;49(7):101826
pubmed: 32505805
Clin Infect Dis. 2020 Nov 19;71(16):2300-2302
pubmed: 32382755
JAMA. 2020 Apr 28;323(16):1574-1581
pubmed: 32250385
Cell Metab. 2020 Jun 2;31(6):1068-1077.e3
pubmed: 32369736
Obesity (Silver Spring). 2020 Jul;28(7):1200-1204
pubmed: 32352637
Diabetes Care. 2020 Jul;43(7):1392-1398
pubmed: 32409502
Nature. 2020 Aug;584(7821):430-436
pubmed: 32640463
BMJ. 2020 May 22;369:m1966
pubmed: 32444366
Eur J Endocrinol. 2020 Oct;183(4):389-397
pubmed: 32674071
JAMA. 2020 May 26;323(20):2052-2059
pubmed: 32320003
Metabolism. 2020 Jul;108:154262
pubmed: 32422233
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
J Pediatr. 2020 Aug;223:14-19.e2
pubmed: 32407719
N Engl J Med. 2020 Jun 11;382(24):2372-2374
pubmed: 32302078
Intensive Care Med. 2019 Jun;45(6):757-769
pubmed: 30888440
J Clin Med. 2020 Feb 20;9(2):
pubmed: 32093211
Obes Facts. 2020;13(4):430-438
pubmed: 32659766
Lancet Diabetes Endocrinol. 2021 Jun;9(6):350-359
pubmed: 33932335
Lancet Diabetes Endocrinol. 2020 Jul;8(7):562-564
pubmed: 32437642
Obesity (Silver Spring). 2020 Sep;28(9):1600-1605
pubmed: 32463545
N Engl J Med. 2020 May 21;382(21):1973-1975
pubmed: 32202721
Obesity (Silver Spring). 2020 Aug;28(8):1371-1373
pubmed: 32397007
J Crit Care. 2019 Oct;53:25-31
pubmed: 31174173
Obesity (Silver Spring). 2021 Sep;29(9):1477-1486
pubmed: 33966355
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Crit Care. 2020 Jul 9;24(1):405
pubmed: 32646459
Clin Infect Dis. 2021 May 4;72(9):e240-e248
pubmed: 32697835
J Med Virol. 2020 Oct;92(10):1915-1921
pubmed: 32293753
Diabetologia. 2020 Aug;63(8):1500-1515
pubmed: 32472191
J Clin Endocrinol Metab. 2020 Aug 1;105(8):
pubmed: 32474598
Obesity (Silver Spring). 2020 Jul;28(7):1195-1199
pubmed: 32271993
Lancet. 2020 May 16;395(10236):1544-1545
pubmed: 32380044
Menopause. 2010 Jul;17(4):718-26
pubmed: 20216473
BMJ. 2020 May 22;369:m1985
pubmed: 32444460

Auteurs

Mikael Chetboun (M)

Univ Lille, Inserm, Lille Pasteur Institute, European Genomic Institute for Diabetes, U1190, F-59000, Lille, France.
CHU Lille, Centre Intégré de l'Obésité, F-59000, Lille, France.

Violeta Raverdy (V)

Univ Lille, Inserm, Lille Pasteur Institute, European Genomic Institute for Diabetes, U1190, F-59000, Lille, France.
CHU Lille, Centre Intégré de l'Obésité, F-59000, Lille, France.

Julien Labreuche (J)

ULR 2694 - METRICS: Assessment of Health Technologies and Medical Practices, Univ Lille, CHU Lille, Lille, France.

Arthur Simonnet (A)

Department of Intensive Care, CHU Lille, Univ Lille, Lille, France.

Florent Wallet (F)

Medical Intensive Care Unit, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite, France.
Emerging Pathogens Laboratory-Mérieux Foundation, International Center for Infectious Disease Research, Inserm U1111, Lyon, France.

Cyrielle Caussy (C)

Diabetes and Nutrition, Department of Endocrinology, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite, France.
CarMen Laboratory, University of Lyon, INRA, INSA, Claude Bernard Lyon 1 University, Inserm, Pierre-Bénite, France.

Massimo Antonelli (M)

Department of Anesthesia and Intensive Care Medicine, Fondazione Policlinico Universitario, A. Gemelli IRCCS, Rome, Italy.

Antonio Artigas (A)

Critical Care Department, Parc Tauli University Health Corporation, CIBER Respiratory Diseases, Sabadell, Spain.
Department of Medicine, Autonomous University of Barcelona, Bellaterra, Spain.

Gemma Goma (G)

Critical Care Department, Parc Tauli University Health Corporation, Sabadell, Spain.

Ferhat Meziani (F)

Intensive Care Medicine Department, Strasbourg University Hospital, University of Strasbourg, Strasbourg, France.
Inserm U1260, Regenerative Nanomedicine, University of Strasbourg, Strasbourg, France.

Julie Helms (J)

Intensive Care Medicine Department, Strasbourg University Hospital, University of Strasbourg, Strasbourg, France.
Inserm Unit_S1109, LabEx TRANSPLANTEX, Immunology and Hematology Research Center, Faculty of Medicine, University of Strasbourg, Strasbourg, France.

Eleftherios Mylonakis (E)

Infectious Diseases Division, Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA.
Rhode Island Hospital and the Miriam Hospital, Providence, Rhode Island, USA.

Mitchell M Levy (MM)

Rhode Island Hospital and the Miriam Hospital, Providence, Rhode Island, USA.
Division of Critical Care, Pulmonary, and Sleep Medicine, Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA.

Markos Kalligeros (M)

Infectious Diseases Division, Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA.
Rhode Island Hospital and the Miriam Hospital, Providence, Rhode Island, USA.

Nicola Latronico (N)

Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, Bresica, Italy.
Department of Anesthesia, Critical Care and Emergency, Spedali Civili University Hospital, Brescia, Italy.

Simone Piva (S)

Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, Bresica, Italy.
Department of Anesthesia, Critical Care and Emergency, Spedali Civili University Hospital, Brescia, Italy.

Charles Cerf (C)

Medico-Surgical Intensive Care Unit, Foch Hospital, Suresnes, France.

Mathilde Neuville (M)

Medico-Surgical Intensive Care Unit, Foch Hospital, Suresnes, France.

Kada Klouche (K)

Department of Intensive Care Medicine, Lapeyronie University Hospital, Montpellier, France.
PhyMedExp, University of Montpellier, Inserm, CNRS, Montpellier, France.

Romaric Larcher (R)

Department of Intensive Care Medicine, Lapeyronie University Hospital, Montpellier, France.
PhyMedExp, University of Montpellier, Inserm, CNRS, Montpellier, France.

Fabienne Tamion (F)

Medical Intensive Care Unit, University Hospital, Rouen, France.
Normandie Univ, UNIROUEN, Inserm U1096, FHU- REMOD-VHF, Rouen, France.

Emilie Occhiali (E)

Department of Anesthesia, Critical Care and Perioperative Medecine, Rouen University Hospital, Rouen, France.

Morgane Snacken (M)

Department of Intensive Care, Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium.

Jean-Charles Preiser (JC)

Department of Intensive Care, Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium.

Loay Kontar (L)

Medical Intensive Care Unit, Amiens University Hospital, Amiens, France.

Antoine Riviere (A)

Intensive Care Unit, Abbeville General Hospital, Abbeville, France.

Stein Silva (S)

Critical Care Unit, University Hospital of Purpan, Toulouse, France.
ToNIC, Toulouse NeuroImaging Center, Inserm 1214, Paul Sabatier University, Toulouse, France.

Benjamine Sarton (B)

Critical Care Unit, University Hospital of Purpan, Toulouse, France.
ToNIC, Toulouse NeuroImaging Center, Inserm 1214, Paul Sabatier University, Toulouse, France.

Raphael Krouchi (R)

Intensive Care Unit, Dunkerque Hospital Center, Dunkerque, France.

Victoria Dubar (V)

Intensive Care Unit, Dunkerque Hospital Center, Dunkerque, France.

Leonidas Palaiodimos (L)

Division of Hospital Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York, USA.

Dimitrios Karamanis (D)

Department of Economics, University of Piraeus, Piraeus, Attica, Greece.

Juliette Perche (J)

Roubaix Hospital, Intensive Care Unit, Roubaix, France.

Erwan L'Her (E)

Intensive Care Unit, Regional University Hospital of Brest La Cavale Blanche, Brest, France.
LATIM Inserm UMR 1101, Université de Bretagne Occidentale, Brest, France.

Luca Busetto (L)

Department of Medicine, University of Padova, Padova, Italy.

Dror Dicker (D)

Internal Medicine D, Hasharon Hospital-Rabin Medical Center, Petach-Tikva, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Shaul Lev (S)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
General Intensive Care Unit, Hasharon Hospital-Rabin Medical Center, Petach-Tikva, Israel.

Alain Duhamel (A)

ULR 2694 - METRICS: Assessment of Health Technologies and Medical Practices, Univ Lille, CHU Lille, Lille, France.

Mercè Jourdain (M)

Univ Lille, Inserm, Lille Pasteur Institute, European Genomic Institute for Diabetes, U1190, F-59000, Lille, France.
Department of Intensive Care, CHU Lille, Univ Lille, Lille, France.

François Pattou (F)

Univ Lille, Inserm, Lille Pasteur Institute, European Genomic Institute for Diabetes, U1190, F-59000, Lille, France.
CHU Lille, Centre Intégré de l'Obésité, F-59000, Lille, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH